• $7,077.00
    Market Cap
  • -98.95%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
06/30/2024
06/30/2023
06/30/2022
06/30/2021
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
0
N/A
N/A
N/A
0
N/A
N/A
N/A
Research and Development Expense
0
N/A
0
N/A
0
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
223,255
0.00%
223,255
-79.59%
1.1M
-52.52%
Total Operating Expenses
155,663
-44.92%
282,608
-49.89%
563,992
-69.41%
1.8M
-30.99%
Operating Profit
-239,113
-33.93%
-361,902
-42.22%
-626,357
-66.32%
-1.9M
-30.38%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-35,287
+19.49%
-29,531
+64.56%
-17,945
N/A
N/A
N/A
Interest Income and Expense and Net
-35,287
+19.49%
-29,531
+64.56%
-17,945
N/A
0
+100.00%
Total Nonoperating Income and Expense
-83,450
+5.24%
-79,294
+27.15%
-62,365
+285.56%
-16,175
+48,915.15%
Income before Taxes
-239,113
-33.93%
-361,902
-42.22%
-626,357
-66.32%
-1.9M
-30.38%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-239,113
-33.93%
-361,902
-42.22%
-626,357
-66.32%
-1.9M
-30.38%
Net Income from Continuing Operations Applicable to Common
-239,113
-33.93%
-361,902
-42.22%
-626,357
-66.32%
-1.9M
-30.38%
Basic EPS and Net Income
0.00
+100.00%
-0.01
0.00%
-0.01
-66.67%
-0.03
-40.00%
Diluted EPS and Net Income
0.00
+100.00%
-0.01
0.00%
-0.01
-66.67%
-0.03
-40.00%
Basic Weighted Average Shares
66.2M
+6.19%
62.3M
+7.73%
57.9M
+4.44%
55.4M
+2.76%
Diluted Weighted Average Shares
66.2M
+6.19%
62.3M
+7.73%
57.9M
+4.44%
55.4M
+2.76%
Balance Sheet
Cash and Cash Equivalents
4,183
-88.10%
35,147
-69.93%
116,898
+547.96%
18,041
+67.26%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4,183
-88.10%
35,147
-69.93%
116,898
+547.96%
18,041
+67.26%
Total Current Assets
4,183
-90.30%
43,127
-65.36%
124,518
+387.52%
25,541
+12.09%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
4,183
-90.30%
43,127
-65.36%
124,518
+387.52%
25,541
+12.09%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
318,854
+40.78%
226,491
+59.30%
142,180
+998.68%
12,941
+7.84%
Total Current Liabilities
365,432
+23.82%
295,134
+21.89%
242,123
+515.84%
39,316
+34.87%
Total Long-Term Debt
25,000
0.00%
25,000
0.00%
25,000
-34.21%
38,000
+192.31%
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
365,432
+23.82%
295,134
+21.89%
242,123
+515.84%
39,316
+34.87%
Retained Earnings
-11.5M
+2.12%
-11.3M
+3.31%
-10.9M
+6.08%
-10.3M
+22.02%
Total Stockholders Equity
-361,249
+43.35%
-252,007
+114.28%
-117,605
+753.76%
-13,775
+116.42%
Total Shares Outstanding
70.5M
+10.07%
64.0M
+5.78%
60.5M
+8.52%
55.8M
+3.31%
Cash Flow
Cash from Operating Activities
-64,364
-21.27%
-81,751
+8.79%
-75,143
-17.19%
-90,745
-38.51%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
33,400
N/A
N/A
N/A
174,000
+77.55%
98,000
+716.67%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-1,010.83%
+134.13%
-431.75%
-48.28%
-834.81%
-89.15%
-7,697.32%
+380.37%
Return on Equity
77.98%
-60.18%
195.83%
-79.46%
953.50%
-94.84%
18,470.13%
+997.21%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.01
-92.20%
0.15
-71.59%
0.51
-20.83%
0.65
-16.90%
Cash Ratio
0.01
-90.43%
0.12
-75.33%
0.48
+5.21%
0.46
+24.03%
Debt-to-Equity Ratio
-0.95
-4.63%
-1.00
-29.79%
-1.42
-61.56%
-3.70
-5.85%
Debt-to-Assets Ratio
82.20
+1,309.66%
5.83
+334.34%
1.34
-32.68%
1.99
+81.78%

Earnings & Revenue History

Debt-to-Assets

Cash Flow